Variant report
Variant | esv18629 |
---|---|
Chromosome Location | chr5:150954478-150955343 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs189913179 | chr5:150954481-150954482 | Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs35568803 | chr5:150954487-150954488 | Weak transcription Genic enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs67077732 | chr5:150954488-150954489 | Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs7730502 | chr5:150954489-150954490 | Weak transcription Genic enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs34594701 | chr5:150954490-150954491 | Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs568317249 | chr5:150954509-150954510 | Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs576689838 | chr5:150954574-150954575 | Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs7710596 | chr5:150954587-150954588 | Weak transcription Genic enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
9 | rs4958460 | chr5:150954648-150954649 | Weak transcription Genic enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
10 | rs528850186 | chr5:150954652-150954653 | Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs554654575 | chr5:150954706-150954707 | Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs142013768 | chr5:150954713-150954714 | Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs35237736 | chr5:150954820-150954821 | Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs116591249 | chr5:150954831-150954832 | Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs73273970 | chr5:150954836-150954837 | Weak transcription Genic enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs145893222 | chr5:150954874-150954875 | Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs4416593 | chr5:150954886-150954887 | Weak transcription Genic enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs4416594 | chr5:150954941-150954942 | Weak transcription Genic enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs114653726 | chr5:150954952-150954953 | Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs115201368 | chr5:150954958-150954959 | Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs535825880 | chr5:150954967-150954968 | Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs4452546 | chr5:150954975-150954976 | Weak transcription Genic enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs566667852 | chr5:150955003-150955004 | Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs543382864 | chr5:150955074-150955075 | Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs566059090 | chr5:150955082-150955083 | Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs375731517 | chr5:150955101-150955102 | Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs138791935 | chr5:150955102-150955103 | Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs4416595 | chr5:150955127-150955128 | Weak transcription Genic enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs4314387 | chr5:150955141-150955142 | Weak transcription Genic enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs140281857 | chr5:150955145-150955146 | Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs4376256 | chr5:150955163-150955164 | Weak transcription Genic enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs560043869 | chr5:150955225-150955226 | Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs11746958 | chr5:150955242-150955243 | Weak transcription Genic enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs184116169 | chr5:150955281-150955282 | Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs13167092 | chr5:150955282-150955283 | Weak transcription Genic enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs559272546 | chr5:150955305-150955306 | Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs11750312 | chr5:150955332-150955333 | Weak transcription Genic enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs545044441 | chr5:150955341-150955342 | Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Lung cancer | 18438408 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Renal cell carcinoma | 19377443 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18316590 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Hyperekplexia | 16941485 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Crohn''s disease | 20877625 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Breast cancer | 17603634 | CNVD |
Crohn''s disease | 20106866 | CNVD |
Breast cancer | 20409316 | CNVD |
Basal cell lymphoma | 19029149 | CNVD |
Diffuse large b-cell lymphoma | 19029149 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Prostate cancer | 18632612 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:150951200-150960400 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
2 | chr5:150951400-150959600 | Weak transcription | Placenta | Placenta |
3 | chr5:150951600-150955800 | Weak transcription | Primary B cells from cord blood | blood |
4 | chr5:150951600-150956400 | Weak transcription | Primary B cells from peripheral blood | blood |
5 | chr5:150951600-150960400 | Genic enhancers | NHEK | skin |
6 | chr5:150952000-150955800 | Genic enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
7 | chr5:150952600-150957000 | Genic enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
8 | chr5:150953400-150956000 | Genic enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
9 | chr5:150953600-150955400 | Genic enhancers | HMEC | breast |
10 | chr5:150953600-150955600 | Genic enhancers | Breast Myoepithelial Primary Cells | Breast |
11 | chr5:150953600-150956800 | Weak transcription | Fetal Thymus | thymus |
12 | chr5:150954000-150959600 | Weak transcription | Esophagus | oesophagus |